MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Illumina Inc

Închisă

SectorSănătate

76.39 -6.75

Rezumat

Modificarea prețului

24h

Curent

Minim

76.13

Maxim

81.85

Indicatori cheie

By Trading Economics

Venit

187M

Vânzări

24M

1.1B

EPS

0.86

Marjă de profit

16.938

Angajați

8,970

EBITDA

54M

283M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+54.96% upside

Dividende

By Dow Jones

Următoarele câștiguri

1 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-8.7B

13B

Deschiderea anterioară

83.14

Închiderea anterioară

76.39

Sentimentul știrilor

By Acuity

58%

42%

328 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Illumina Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 mar. 2025, 09:18 UTC

Acțiuni populare

Stocks to Watch Tuesday: Tesla, Oracle, Delta, Nvidia -- WSJ

10 mar. 2025, 21:07 UTC

Top știri

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

10 mar. 2025, 20:01 UTC

Top știri

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

4 mar. 2025, 10:56 UTC

Acțiuni populare

Stocks to Watch Tuesday: Illumina, Nvidia, Stellantis -- WSJ

Comparație

Modificare preț

Illumina Inc Așteptări

Obiectiv de preț

By TipRanks

54.96% sus

Prognoză pe 12 luni

Medie 126.88 USD  54.96%

Maxim 190 USD

Minim 90 USD

În baza a 19 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIllumina Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

19 ratings

9

Cumpărare

8

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

77.54 / 87.66Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

328 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.